Total phenolic content (TPC) and total flavonoid content (TFC) in ginger extract obtained from conventional maceration and pulsed electric field extraction. by Hataichanok Chuljerm (19144293)

Subjects:

Graphical abstract_6-Shogaol ginger. by Hataichanok Chuljerm (19144293)

Subjects:

The concentration of 6-gingerol (A) and 6-shogaol (B) in the ginger extract obtained from conventional maceration and pulsed electric field (PEF) extraction. by Hataichanok Chuljerm (19144293)

Subjects:

Susceptibility of thalassemic and healthy RBCs to hemolysis (A) and the anti-hemolytic activity of 6-shogaol-rich ginger extract (0–200 µg/mL) compared to ascorbic acid (AA; 100 µg... by Hataichanok Chuljerm (19144293)

Subjects:

The percentage of DPPH^• (A) and ABTS^•+ (B) inhibition of 6-shogaol-rich ginger extract and Trolox. by Hataichanok Chuljerm (19144293)

Subjects:

EF-24 induces significant transcriptional changes in K-562 cells. by Ajeet P. Singh (22298432)

Subjects:

IL-10 plasma levels in dengue patients with different clinical severities. by Do Duc Anh (17873834)

CSB elemental content. by Shiqi Zhang (709298)

Subjects:

Changes in rumen fluid metabolites. by Shiqi Zhang (709298)

Subjects:

Rumen fermentation parameters. by Shiqi Zhang (709298)

Subjects:

Rumen microflora gene primer information. by Shiqi Zhang (709298)

Subjects:

Feed nutrient disappearance rate. by Shiqi Zhang (709298)

Subjects:

Rumen bacterial and archaeal diversity. by Shiqi Zhang (709298)

Subjects:

Changes in blood warfarin levels. by Yuki Tatara (13730194)

Subjects:

Obese <i>mMgat2</i> and <i>HuMgat2</i> mice show defects in Akt insulin signaling. by J. Jose Corbalan (22439198)

Subjects:

Under steatotic conditions, primary <i>mMgat2</i> and <i>HuMgat2</i> hepatocytes induce apoptosis. by J. Jose Corbalan (22439198)

Subjects:

<i>mMgat2</i> and <i>HuMgat2</i> mice become obese when fed a HFD. by J. Jose Corbalan (22439198)

Subjects:

Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. by J Mark Ansermino (13958512)

Subjects: